Literature DB >> 3488529

Peritoneal fluid volume, estrogen, progesterone, prostaglandin, and epidermal growth factor concentrations in patients with and without endometriosis.

F D De Leon, R Vijayakumar, M Brown, C V Rao, M A Yussman, G Schultz.   

Abstract

Elevated prostaglandin (PG) levels in peritoneal fluid have been implicated as playing a role in infertility associated with endometriosis. This study was designed to measure peritoneal fluid levels of PG and other hormones that may influence PG release. Specific hormones measured included PGF2 alpha, PGE2, TxB2, 6-keto-PGF1 alpha, estrogen, progesterone, and epidermal growth factor. Peritoneal fluid volume and levels of estrogen, progesterone, and epidermal growth factor were significantly (P less than .05) increased during the secretory, as opposed to the proliferative, phase in both groups of patients, but no significant differences in these parameters were found between patients with and without endometriosis during either the proliferative or secretory phases. Although PG levels did not vary during the menstrual cycle in either group of patients, all four prostanoids were present in significantly (P less than .05) higher concentrations in patients with endometriosis as compared with patients without endometriosis. Furthermore, increased PG levels in patients with endometriosis appear to be due primarily to an increase in PG levels during the secretory phase of the cycle.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3488529

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  11 in total

1.  Physiological and cytogenetic characterization of immortalized human endometriotic cells containing episomal simian virus 40 DNA.

Authors:  A Akoum; J Lavoie; R Drouin; C Jolicoeur; A Lemay; R Maheux; E W Khandjian
Journal:  Am J Pathol       Date:  1999-04       Impact factor: 4.307

2.  Antioxidant supplementation reduces endometriosis-related pelvic pain in humans.

Authors:  Nalini Santanam; Nino Kavtaradze; Ana Murphy; Celia Dominguez; Sampath Parthasarathy
Journal:  Transl Res       Date:  2012-05-31       Impact factor: 7.012

3.  Prostaglandin E2 receptor EP1 in healthy and diseased human endometrium.

Authors:  Junyan Zhu; Doris Mayr; Christina Kuhn; Sven Mahner; Udo Jeschke; Viktoria von Schönfeldt
Journal:  Histochem Cell Biol       Date:  2017-11-13       Impact factor: 4.304

4.  Vascular endothelial growth factor is produced by peritoneal fluid macrophages in endometriosis and is regulated by ovarian steroids.

Authors:  J McLaren; A Prentice; D S Charnock-Jones; S A Millican; K H Müller; A M Sharkey; S K Smith
Journal:  J Clin Invest       Date:  1996-07-15       Impact factor: 14.808

5.  Molecular and preclinical basis to inhibit PGE2 receptors EP2 and EP4 as a novel nonsteroidal therapy for endometriosis.

Authors:  Joe A Arosh; JeHoon Lee; Dakshnapriya Balasubbramanian; Jone A Stanley; Charles R Long; Mary W Meagher; Kevin G Osteen; Kaylon L Bruner-Tran; Robert C Burghardt; Anna Starzinski-Powitz; Sakhila K Banu
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-21       Impact factor: 11.205

6.  Catechol-O-methyltransferase polymorphism and endometriosis.

Authors:  Fritz Wieser; Rene Wenzl; Clemens Tempfer; Christoph Worda; Johannes Huber; Christian Schneeberger
Journal:  J Assist Reprod Genet       Date:  2002-07       Impact factor: 3.412

7.  Selective inhibition of prostaglandin E2 receptors EP2 and EP4 inhibits adhesion of human endometriotic epithelial and stromal cells through suppression of integrin-mediated mechanisms.

Authors:  JeHoon Lee; Sakhila K Banu; Robert C Burghardt; Anna Starzinski-Powitz; Joe A Arosh
Journal:  Biol Reprod       Date:  2013-03-28       Impact factor: 4.285

8.  Selective inhibition of prostaglandin E2 receptors EP2 and EP4 induces apoptosis of human endometriotic cells through suppression of ERK1/2, AKT, NFkappaB, and beta-catenin pathways and activation of intrinsic apoptotic mechanisms.

Authors:  Sakhila K Banu; JeHoon Lee; V O Speights; Anna Starzinski-Powitz; Joe A Arosh
Journal:  Mol Endocrinol       Date:  2009-04-30

9.  Effect of octreotide on endometriosis in acromegaly: Case report with review of literature.

Authors:  Seerat Singh; Aditi Anupam Chakravarty; Smita Manchanda; Renuka Mallik; Shweta Chopra; Ajay Ajmani; Bindu Kulshreshtha
Journal:  Indian J Endocrinol Metab       Date:  2014-03

Review 10.  Recent advances in the understanding of endometriosis: the role of inflammatory mediators in disease pathogenesis and treatment.

Authors:  Warren Nothnick; Zahraa Alali
Journal:  F1000Res       Date:  2016-02-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.